SEARCH

SEARCH BY CITATION

References

  • Bourinet E, Alloui A, Monteil A, Barrere C, Couette B, Poirot O et al. (2005). Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 24: 315324.
  • Chemin J, Nargeot J, Lory P (2002). Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. J Neurosci 22: 68566862.
  • Chemin J, Mezghrani A, Bidaud I, Dupasquier S, Marger F, Barrere C et al. (2007). Temperature-dependent modulation of Cav3 T-type calcium channels by protein kinases C and A in mammalian cells. J Biol Chem 282: 3271032718.
  • Chen WK, Liu IY, Chang YT, Chen YC, Chen CC, Yen CT et al. (2010). Cav3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain. J Neurosci 30: 1036010368.
  • Choe W, Messinger RB, Leach E, Eckle VS, Obradovic A, Salajegheh R et al. (2011). TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent. Mol Pharmacol 80: 900910.
  • Choi S, Na HS, Kim J, Lee J, Lee S, Kim D et al. (2007). Attenuated pain responses in mice lacking Cav3.2 T-type channels. Genes Brain Behav 6: 425431.
  • Clark P, Rowland SE, Denis D, Mathieu MC, Stocco R, Poirier H et al. (2008). MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-m ethylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis. J Pharmacol Exp Ther 325: 425434.
  • Colucci J, Boyd M, Berthelette C, Chiasson JF, Wang Z, Ducharme Y et al. (2010). Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopr opyl]benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain. Bioorg Med Chem Lett 20: 37603763.
  • Dogrul A, Gardell LR, Ossipov MH, Tulunay FC, Lai J, Porreca F (2003). Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 105: 159168.
  • Gylys KH, Tran N, Magendzo K, Zaki P, Evans CJ (1997). cAMP decreases steady-state levels of delta-opioid receptor mRNA in NG108-15 cells. Neuroreport 8: 23692372.
  • Holz GG, Kang G, Harbeck M, Roe MW, Chepurny OG (2006). Cell physiology of cAMP sensor Epac. J Physiol 577: 515.
  • Hu C, Depuy SD, Yao J, McIntire WE, Barrett PQ (2009). Protein kinase A activity controls the regulation of T-type Cav3.2 channels by Gbetagamma dimers. J Biol Chem 284: 74657473.
  • Jeske NA, Diogenes A, Ruparel NB, Fehrenbacher JC, Henry M, Akopian AN et al. (2008). A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1. Pain 138: 604616.
  • Jeske NA, Patwardhan AM, Ruparel NB, Akopian AN, Shapiro MS, Henry MA (2009). A-kinase anchoring protein 150 controls protein kinase C-mediated phosphorylation and sensitization of TRPV1. Pain 146: 301307.
  • Kaneko S, Akaike A, Satoh M (1998). Differential regulation of N- and Q-type Ca2+ channels by cyclic nucleotides and G-proteins. Life Sci 62: 15431547.
  • Kawabata A (2011). Prostaglandin E2 and pain: an update. Biol Pharm Bull 34: 11701173.
  • Kawabata A, Ishiki T, Nagasawa K, Yoshida S, Maeda Y, Takahashi T et al. (2007). Hydrogen sulfide as a novel nociceptive messenger. Pain 132: 7481.
  • Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010) NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160:1577-1579.
  • Kim JA, Park JY, Kang HW, Huh SU, Jeong SW, Lee JH (2006). Augmentation of Cav3.2 T-type calcium channel activity by cAMP-dependent protein kinase A. J Pharmacol Exp Ther 318: 230237.
  • Kohno D, Gao HZ, Muroya S, Kikuyama S, Yada T (2003). Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 52: 948956.
  • Latham JR, Pathirathna S, Jagodic MM, Choe WJ, Levin ME, Nelson MT et al. (2009). Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes 58: 26562665.
  • Lee WY, Orestes P, Latham J, Naik AK, Nelson MT, Vitko I et al. (2009). Molecular mechanisms of lipoic acid modulation of T-type calcium channels in pain pathway. J Neurosci 29: 95009509.
  • Lin CR, Amaya F, Barrett L, Wang H, Takada J, Samad TA et al. (2006). Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity. J Pharmacol Exp Ther 319: 10961103.
  • Liu H, Enyeart JA, Enyeart JJ (2010). ACTH induces Cav3.2 current and mRNA by cAMP-dependent and cAMP-independent mechanisms. J Biol Chem 285: 2004020050.
  • Maeda Y, Aoki Y, Sekiguchi F, Matsunami M, Takahashi T, Nishikawa H et al. (2009). Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels. Pain 142: 127132.
  • Matsunami M, Tarui T, Mitani K, Nagasawa K, Fukushima O, Okubo K et al. (2009). Luminal hydrogen sulfide plays a pronociceptive role in mouse colon. Gut 58: 751761.
  • Matsunami M, Kirishi S, Okui T, Kawabata A (2011). Chelating luminal zinc mimics H2S-evoked colonic pain in mice: possible involvement of T-type Ca2+ channels. Neuroscience 181: 257264.
  • McGrath J, Drummond G, Kilkenny C, Wainwright C (2010). Guidelines for reportingexperiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 15731576.
  • Miki T, Matsunami M, Nakamura S, Okada H, Matsuya H, Kawabata A (2011). ONO-8130, a selective prostanoid EP1 receptor antagonist, relieves bladder pain in mice with cyclophosphamide-induced cystitis. Pain 150: 13731381.
  • Moriyama T, Higashi T, Togashi K, Iida T, Segi E, Sugimoto Y et al. (2005). Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain 1: 3.
  • Murase A, Okumura T, Sakakibara A, Tonai-Kachi H, Nakao K, Takada J (2008a). Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation. Eur J Pharmacol 580: 116121.
  • Murase A, Taniguchi Y, Tonai-Kachi H, Nakao K, Takada J (2008b). In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP4 receptor antagonist. Life Sci 82: 226232.
  • Nagasawa K, Tarui T, Yoshida S, Sekiguchi F, Matsunami M, Ohi A et al. (2009). Hydrogen sulfide evokes neurite outgrowth and expression of high-voltage-activated Ca2+ currents in NG108-15 cells: involvement of T-type Ca2+ channels. J Neurochem 108: 676684.
  • Nakao K, Murase A, Ohshiro H, Okumura T, Taniguchi K, Murata Y et al. (2007). CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 322: 686694.
  • Narumiya S, FitzGerald GA (2001). Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 108: 2530.
  • Nelson MT, Woo J, Kang HW, Vitko I, Barrett PQ, Perez-Reyes E et al. (2007). Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels. J Neurosci 27: 82508260.
  • Nishimura S, Fukushima O, Ishikura H, Takahashi T, Matsunami M, Tsujiuchi T et al. (2009). Hydrogen sulfide as a novel mediator for pancreatic pain in rodents. Gut 58: 762770.
  • Okubo K, Takahashi T, Sekiguchi F, Kanaoka D, Matsunami M, Ohkubo T et al. (2011). Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats. Neuroscience 188: 148156.
  • Okubo K, Matsumura M, Kawaishi Y, Aoki Y, Matsunami M, Okawa Y et al. (2012). Hydrogen sulfide-induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice. Br J Pharmacol 166: 17381743.
  • Park JY, Kang HW, Moon HJ, Huh SU, Jeong SW, Soldatov NM et al. (2006). Activation of protein kinase C augments T-type Ca2+ channel activity without changing channel surface density. J Physiol 577: 513523.
  • Rangel A, Sanchez-Armass S, Meza U (2010). Protein kinase C-mediated inhibition of recombinant T-type Cav3.2 channels by neurokinin 1 receptors. Mol Pharmacol 77: 202210.
  • Reinold H, Ahmadi S, Depner UB, Layh B, Heindl C, Hamza M et al. (2005). Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest 115: 673679.
  • Rola R, Jarkiewicz M, Szulczyk P (2008). Modulation of Ca2+ channel current by mu opioid receptors in prefrontal cortex pyramidal neurons in rats. Acta Neurobiol Exp (Wars) 68: 1025.
  • Sachs D, Villarreal C, Cunha F, Parada C, Ferreira S (2009). The role of PKA and PKCepsilon pathways in prostaglandin E2-mediated hypernociception. Br J Pharmacol 156: 826834.
  • Schnizler K, Shutov LP, Van Kanegan MJ, Merrill MA, Nichols B, McKnight GS et al. (2008). Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons. J Neurosci 28: 49044917.
  • Takahashi T, Aoki Y, Okubo K, Maeda Y, Sekiguchi F, Mitani K et al. (2010). Upregulation of Cav3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain. Pain 150: 183191.
  • Tarui T, Fukami K, Nagasawa K, Yoshida S, Sekiguchi F, Kawabata A (2010). Involvement of Src kinase in T-type calcium channel-dependent neuronal differentiation of NG108-15 cells by hydrogen sulfide. J Neurochem 114: 512519.
  • Todorovic SM, Jevtovic-Todorovic V (2011). T-type voltage-gated calcium channels as targets for the development of novel pain therapies. Br J Pharmacol 163: 484495.
  • Todorovic SM, Jevtovic-Todorovic V, Meyenburg A, Mennerick S, Perez-Reyes E, Romano C et al. (2001). Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron 31: 7585.
  • Todorovic SM, Meyenburg A, Jevtovic-Todorovic V (2004). Redox modulation of peripheral T-type Ca2+ channels in vivo: alteration of nerve injury-induced thermal hyperalgesia. Pain 109: 328339.
  • Traboulsie A, Chemin J, Chevalier M, Quignard JF, Nargeot J, Lory P (2007). Subunit-specific modulation of T-type calcium channels by zinc. J Physiol 578: 159171.
  • Varga A, Nemeth J, Szabo A, McDougall JJ, Zhang C, Elekes K et al. (2005). Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat. Neurosci Lett 385: 137142.
  • Vijayaraghavan S, Goueli SA, Davey MP, Carr DW (1997). Protein kinase A-anchoring inhibitor peptides arrest mammalian sperm motility. J Biol Chem 272: 47474752.
  • Welch EJ, Jones BW, Scott JD (2010). Networking with AKAPs: context-dependent regulation of anchored enzymes. Mol Interv 10: 8697.
  • Zhang X, Li L, McNaughton PA (2008). Proinflammatory mediators modulate the heat-activated ion channel TRPV1 via the scaffolding protein AKAP79/150. Neuron 59: 450461.
  • Zhang Y, Zhang L, Wang F, Wang J, Qin Z, Jiang X et al. (2011). Activation of M3 muscarinic receptors inhibits T-type Ca2+ channel currents via pertussis toxin-sensitive novel protein kinase C pathway in small dorsal root ganglion neurons. Cell Signal 23: 10571067.